4.6 Article

Trends in global amyotrophic lateral sclerosis research from 2000 to 2022: A bibliometric analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Urinary p75ECD levels in patients with amyotrophic lateral sclerosis: a meta-analysis

Guanzhong Shi et al.

Summary: This study found significantly higher levels of urinary p75(ECD) in ALS patients, which were inversely correlated with disease severity, suggesting the potential of urinary p75(ECD) levels as diagnostic biomarkers and progression indicators in the future.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2022)

Article Clinical Neurology

Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis

Sara Salvany et al.

Summary: Early misfolded superoxide dismutase 1 (mfSOD1) accumulation, motor neuron (MN) degeneration, and microgliosis are hallmark pathological features in SOD1(G93A) amyotrophic lateral sclerosis (ALS) mice. Different MN subtypes exhibit varying vulnerabilities, leading to the coexistence of degenerating and surviving MNs during disease progression. The most severe phenotype is observed in fast-twitch subtype MNs, which display high levels of mfSOD1 and extensive vacuolar degeneration. Vacuoles, originating from mitochondria, contain mfSOD1 along with nonmitochondrial proteins. The fusion of ER-derived vesicles enriched with mfSOD1 and outer mitochondrial membranes is believed to be the main mechanism for vacuole formation. Vacuolar degeneration occurs transiently in the presymptomatic stages of ALS, and vacuolated MNs also express the effector protein pMLKL, suggesting a mechanism involving extracellular vesicles in neuroinflammation and disease spreading. Additionally, the expression of mfSOD1 and local neuroinflammation demonstrate bidirectional communication, as manipulation of microglial response affects MN phenotypes. Detailed understanding of these processes prior to the end stages of the disease is essential for identifying novel therapeutic targets.

BRAIN PATHOLOGY (2022)

Review Neurosciences

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Federico Verde et al.

Summary: ALS and FTD are currently incurable neurodegenerative diseases lacking specific neurochemical biomarkers, but NFL has shown considerable progress as a biomarker in both diseases, distinguishing them from mimic conditions and providing prognostic information.

FRONTIERS IN NEUROSCIENCE (2021)

Review Clinical Neurology

Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis

Jan Kassubek et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)

Article Critical Care Medicine

Respiratory Failure in Amyotrophic Lateral Sclerosis

Shannon Niedermeyer et al.

Review Chemistry, Medicinal

Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs

Manoj Kumar Jaiswal

MEDICINAL RESEARCH REVIEWS (2019)

Article Computer Science, Interdisciplinary Applications

bibliometrix: An R-tool for comprehensive science mapping analysis

Massimo Aria et al.

JOURNAL OF INFORMETRICS (2017)

Review Biochemistry & Molecular Biology

Necroptosis in amyotrophic lateral sclerosis and other neurological disorders

Jessica R. Morrice et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Review Cell Biology

Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways

Judith M. Silverman et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)

Review Neurosciences

Excitotoxicity in ALS: Overstimulation, or overreaction?

Anna E. King et al.

EXPERIMENTAL NEUROLOGY (2016)

Review Clinical Neurology

Supportive and symptomatic management of amyotrophic lateral sclerosis

Esther V. Hobson et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Biochemistry & Molecular Biology

The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development

H. Blasco et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Review Neurosciences

The changing scene of amyotrophic lateral sclerosis

Wim Robberecht et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Review Public, Environmental & Occupational Health

Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature

A. Chio et al.

NEUROEPIDEMIOLOGY (2013)

Review Neurosciences

An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis

Melissa S. Rotunno et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Review Medicine, General & Internal

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Robert G. Miller et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)

Article Psychology, Developmental

Religiosity, values, and acculturation: A study of Turkish, Turkish-Belgian, and Belgian adolescents

Derya Gungor et al.

INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT (2012)

Article Psychology, Biological

The weirdest people in the world?

Joseph Henrich et al.

BEHAVIORAL AND BRAIN SCIENCES (2010)

Review Biochemistry & Molecular Biology

Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis

B. C. Cheah et al.

CURRENT MEDICINAL CHEMISTRY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Bibliometric Indicators: Quality Measurements of Scientific Publication

Valerie Durieux et al.

RADIOLOGY (2010)

Article Political Science

European Culture and the European Union's 'Turkey Question'

John A. Scherpereel

WEST EUROPEAN POLITICS (2010)

Article Computer Science, Interdisciplinary Applications

Relations between national research investment and publication output: Application to an American Paradox

Robert D. Shelton

SCIENTOMETRICS (2008)

Article Multidisciplinary Sciences

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Manuela Neumann et al.

SCIENCE (2006)

Review Multidisciplinary Sciences

Oxidants, oxidative stress and the biology of ageing

T Finkel et al.

NATURE (2000)